This independent RP-HPLC lab test confirms Tirzepatide 64.52mg from Instant Peptides at 99.917% purity. The analysis was conducted by Kovera Labs on March 9, 2026, using validated analytical methods including batch conformity testing across three vials.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 99.917% indicates exceptional product quality with minimal contamination. Endotoxin safety screening returned a PASS result (≤0.5 EU/mL), and heavy metal screening showed negative results for Lead, Cadmium, Arsenic, and Mercury.
The sample appeared as a lyophilized powder in a black-capped vial with silver crimp. Microbial sterility screening showed no growth. The full certificate of analysis (Report #: KVR-2026-934E20) is available for download on this page.

Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.